Insmed Incorporated
INSM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $363,707 | $305,208 | $245,358 | $188,461 |
| % Growth | 19.2% | 24.4% | 30.2% | – |
| Cost of Goods Sold | $85,742 | $65,573 | $55,126 | $44,152 |
| Gross Profit | $277,965 | $239,635 | $190,232 | $144,309 |
| % Margin | 76.4% | 78.5% | 77.5% | 76.6% |
| R&D Expenses | $598,367 | $571,011 | $397,518 | $272,744 |
| G&A Expenses | $461,116 | $344,501 | $265,784 | $234,273 |
| SG&A Expenses | $461,116 | $344,501 | $265,784 | $234,273 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $96,734 | $33,749 | -$15,749 | $12,386 |
| Operating Expenses | $1,156,217 | $949,261 | $647,553 | $519,403 |
| Operating Income | -$878,252 | -$709,626 | -$457,321 | -$375,094 |
| % Margin | -241.5% | -232.5% | -186.4% | -199% |
| Other Income/Exp. Net | -$31,813 | -$37,386 | -$22,830 | -$61,318 |
| Pre-Tax Income | -$910,065 | -$747,012 | -$480,151 | -$436,412 |
| Tax Expense | $3,707 | $2,555 | $1,383 | -$1,758 |
| Net Income | -$913,772 | -$749,567 | -$481,534 | -$434,654 |
| % Margin | -251.2% | -245.6% | -196.3% | -230.6% |
| EPS | -5.57 | -5.34 | -3.91 | -3.88 |
| % Growth | -4.3% | -36.6% | -0.8% | – |
| EPS Diluted | -5.57 | -5.34 | -3.91 | -3.88 |
| Weighted Avg Shares Out | 164,043 | 140,433 | 123,035 | 112,111 |
| Weighted Avg Shares Out Dil | 164,043 | 140,433 | 123,035 | 112,111 |
| Supplemental Information | – | – | – | – |
| Interest Income | $53,307 | $42,132 | $11,081 | $174 |
| Interest Expense | $84,913 | $81,694 | $26,446 | $40,473 |
| Depreciation & Amortization | $11,013 | $10,579 | $10,331 | $14,182 |
| EBITDA | -$818,794 | -$660,177 | -$447,365 | -$383,647 |
| % Margin | -225.1% | -216.3% | -182.3% | -203.6% |